PT  - JOURNAL ARTICLE
AU  - Débarre Florence
AU  - Lecoeur Emmanuel
AU  - Guimier Lucie
AU  - Jauffret-Roustide Marie
AU  - Jannot Anne-Sophie
TI  - The French domestic “sanitary pass” did not solve Covid-19 vaccination inequities in France
AID  - 10.1101/2022.01.03.22268676
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.03.22268676
4099  - http://medrxiv.org/content/early/2022/01/05/2022.01.03.22268676.short
4100  - http://medrxiv.org/content/early/2022/01/05/2022.01.03.22268676.full
AB  - The French sanitary pass led to an increase in vaccination rates in France, but local heterogeneities in vaccination rates remain. To identify potential determinants of these heterogeneities and how the French sanitary pass influenced them, we used a data-driven approach on exhaustive nationwide data, gathering 181 socio-economic and geographic factors. Our analysis reveals that, both before and after the introduction of the French sanitary pass, factors with the largest impact are related to poverty, with the most deprived areas having greater than 10 times the odds of being among the districts with lower vaccination rates.Competing Interest StatementThe authors have declared no competing interest.Funding StatementEL received funding to match socio-economic data with medical data from AP-HP Centre Universite de Paris.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves only openly available data: - INSEE: https://www.insee.fr/fr/statistiques/5359146#consulter - Assurance Maladie: datavaccin-covid.ameli.fr/explore/dataset/donnees-devaccination-par-epci/https://datavaccin-covid.ameli.fr/explore/dataset/donnees-devaccination-par-epci/https://datavaccin-covid.ameli.fr/explore/dataset/donnees-de-vaccination-parcommune/information/ The data are published by official French institutions, are only available in aggregated format, and therefore are not individual data.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study involves only openly available data: - INSEE: https://www.insee.fr/fr/statistiques/5359146#consulter - Assurance Maladie: https://datavaccin-covid.ameli.fr/explore/dataset/donnees-devaccination-par-epci/https://datavaccin-covid.ameli.fr/explore/dataset/donnees-de-vaccination-parcommune/information/ https://www.insee.fr/fr/statistiques/5359146#consulter https://datavaccin-covid.ameli.fr/explore/dataset/donnees-devaccination-par-epci/ https://datavaccin-covid.ameli.fr/explore/dataset/donnees-de-vaccination-parcommune/information/